Early Intensive Treatment May Improve Long-Term MS Outcomes

WEDNESDAY, Feb. 20, 2019 -- Long-term outcomes are more favorable for early intensive treatment (EIT) versus first-line moderate-efficacy disease-modifying therapy (DMT) in multiple sclerosis (MS), according to a study published online Feb. 18 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news